dexmedetomidine has been researched along with Left Heart Hypoplasia Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Subu, AM; Schlueter, SM; Von Bergen, N; Wilhelm, M | 1 |
| Rosen, DA; Thammasitboon, S; Weber, MD | 1 |
2 other study(ies) available for dexmedetomidine and Left Heart Hypoplasia Syndrome
| Article | Year |
|---|---|
Second degree heart block following the administration of dexmedetomidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Cardiac Catheterization; Dexmedetomidine; Electrocardiography; Heart Block; Humans; Hypnotics and Sedatives; Hypoplastic Left Heart Syndrome; Infant; Pacemaker, Artificial; Pain, Procedural | 2019 |
Acute discontinuation syndrome from dexmedetomidine after protracted use in a pediatric patient.
Topics: Analgesia, Epidural; Blood Pressure; Cardiac Catheterization; Cardiovascular Diseases; Child, Preschool; Dexmedetomidine; Fontan Procedure; Heart Rate; Humans; Hypnotics and Sedatives; Hypoplastic Left Heart Syndrome; Male; Midazolam; Substance Withdrawal Syndrome | 2008 |